💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @Allstocknews | 7 |
| @FlashAlert_me | 6 |
| @newsfilterio | 6 |
| @MarcJacksonLA | 4 |
| @TradeWithAlerts | 3 |
Recent Tweets for NBIX
 |
@TradeWithAlerts Large Print $NBIX Size: 106088 Price: 94.85 Time: 1600 Amount: $10,062,446.80 April 19th 2021, 8:04pm |
 |
@stockhoot $NBIX Morgan Stanley Maintains to Overweight : PT $125.00 https://t.co/aoZbmPU9FY April 19th 2021, 2:04pm |
 |
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $NBIX https://t.co/HAzdZwNoeZ April 17th 2021, 5:04am |
|
@newsfilterio 17,180 shares acquired by Mercier Johanna (Director), reported in a new form 4 filed with the SEC $NBIX https://t.co/0HDa8lJoJc April 17th 2021, 5:04am |
 |
@InsiderAlerts4U $NBIX: New Insider Filing on NEUROCRINE BIOSCIENCES INC's Director JOHANNA MERCIER: https://t.co/Qs4nI7jOKb April 16th 2021, 8:04pm |
 |
@Allstocknews $NBIX New Form 3 for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 16th 2021, 8:04pm |
 |
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 4: Director Mercier Johanna: Transacted Derivative Securities on 2021-04-15. https://t.co/frmIKdIWp4 April 16th 2021, 8:04pm |
|
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 3: Director Mercier Johanna: https://t.co/iom9gZB1SF April 16th 2021, 8:04pm |
|
@newsfilterio Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors $NBIX https://t.co/Zg8zgBTAl1 April 16th 2021, 3:04pm |
 |
@MarcJacksonLA $NBIX Neurocrine Biosciences Appoints Johanna Mercier To Board of Directors https://t.co/MQm4JuDZ70 April 16th 2021, 1:04pm |
|
@FlashAlert_me $NBIX [15s. delayed]: Issued Press Release on April 16, 09:00:00: Neurocrine Biosciences Announces Appointment of J… https://t.co/jzXK5FVig4 April 16th 2021, 1:04pm |
 |
@SwingTradeBot Recent $NBIX technical alerts: Non-ADX 1,2,3,4 Bearish plus 3 more alerts... https://t.co/zVcidEswK7 April 16th 2021, 1:04pm |
 |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 8-K https://t.co/I2hDrc2atb April 16th 2021, 1:04pm |
 |
@otcdynamics $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors https://t.co/psjx2rEz45 April 16th 2021, 1:04pm |
|
@Allstocknews $NBIX New Form 8-K for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 16th 2021, 1:04pm |
|
@Allstocknews $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors From our Stock News Alerts App April 16th 2021, 1:04pm |
 |
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $NBIX NEUROCRINE BIOSCIENCES INC https://t.co/3Aegt7YcrN April 16th 2021, 1:04pm |
|
@FlashAlert_me $NBIX [15s. delayed] filed form 8-K on April 16, 09:02:16: Item5.02: Departure of Election 0f Officers or Compensat… https://t.co/QBLUxZv7KX April 16th 2021, 1:04pm |
 |
@stock_titan $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors https://t.co/E4eAWVNRjw April 16th 2021, 1:04pm |
|
@newsfilterio Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results $NBIX https://t.co/B9DUF6yPaK April 15th 2021, 1:04am |
|
@Allstocknews $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results From our Stock News Alerts App April 14th 2021, 9:04pm |
|
@otcdynamics $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results https://t.co/FJiHnYfO4z April 14th 2021, 8:04pm |
|
@FlashAlert_me $NBIX [15s. delayed]: Issued Press Release on April 14, 16:01:00: Neurocrine Biosciences Announces Conference Call… https://t.co/n9qdqY63UV April 14th 2021, 8:04pm |
|
@stock_titan $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results https://t.co/sVyVG2ZudK April 14th 2021, 8:04pm |
|
@MarcJacksonLA $NBIX Neurocrine Biosciences Stock Rating Upgraded by Zacks Investment Research To Buy From Hold, $105 PT… https://t.co/iy0PVu6c6x April 14th 2021, 3:04pm |
 |
@Gambiste1 RT @savage_swings: $NBIX #Earnings 5/4 EPS beat and near sales miss 2/4 Maintained outperform by Wedbush with a 112 PT. Appears to be at su… April 14th 2021, 2:04am |
 |
@savage_swings $NBIX #Earnings 5/4 EPS beat and near sales miss 2/4 Maintained outperform by Wedbush with a 112 PT. Appears to be… https://t.co/bcWsNSmqiy April 14th 2021, 1:04am |
|
@MarcJacksonLA $NBIX Wedbush Analysts Increase Earnings Estimates for Neurocrine Biosciences | https://t.co/NKb5pRLCDo https://t.co/RPSY5Smjqe April 13th 2021, 3:04pm |
 |
@intercooleronli Contrasting Kodiak Sciences $KOD and Neurocrine Biosciences $NBIX https://t.co/NHHZN0jfhY #investingnews April 13th 2021, 12:04am |
|
@TradeWithAlerts Large Print $NBIX Size: 264694 Price: 92.79 Time: 1600 Amount: $24,560,956.26 April 12th 2021, 8:04pm |
 |
@InsiderForms $NBIX JANUS Henderson GROUP PLC has filed Form SC 13G/A with SEC. Reporting 10.0% Ownership. Try Insider Forms mob… https://t.co/V11Vdh70Hd April 12th 2021, 6:04pm |
|
@FlashAlert_me $NBIX [15s. delayed] filed form SC 13G/A on April 12, 14:46:52 https://t.co/PhoZvmBNyV April 12th 2021, 6:04pm |
 |
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 451 April 12th 2021, 5:04pm |
|
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 450 April 12th 2021, 5:04pm |
|
@stockhoot $NBIX Wedbush Maintains to Outperform : PT $112.00 https://t.co/Qvzqpeuyl2 April 12th 2021, 12:04pm |
 |
@Biotech2k1 @TerribleInvest3 I haven't followed in a long time, but I like $NBIX. April 11th 2021, 3:04pm |
 |
@TerribleInvest3 @Biotech2k1 Thanks for the update! ? On another note, would be interesting to hear if you an opinion on $NBIX April 11th 2021, 3:04pm |
|
@newsfilterio Form DEF 14A (other definitive proxy statements) filed with the SEC $NBIX https://t.co/0x581rjKkS April 10th 2021, 3:04am |
|
@newsfilterio Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $NBIX https://t.co/PnBxZ3KRXK April 10th 2021, 3:04am |
|
@Allstocknews $NBIX New Form DEFA14A for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 10th 2021, 12:04am |
|
@Allstocknews $NBIX New Form DEF 14A for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 10th 2021, 12:04am |
 |
@ExecPayOrg Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M https://t.co/52WbidjUtJ $NBIX #execpay April 9th 2021, 9:04pm |
 |
@fintel_io $NBIX / Neurocrine Biosciences files form DEF 14A https://t.co/zFgofVxyvg April 9th 2021, 9:04pm |
 |
@KingsSaddle $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73… https://t.co/wx4sVaDdok April 8th 2021, 10:04pm |
|
@MarcJacksonLA $NBIX Neurocrine Biosciences To Present At American College of Neurology Meeting https://t.co/vjUauDMmml April 8th 2021, 8:04pm |
|
@Allstocknews $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurolog From our Stock News Alerts App April 8th 2021, 8:04pm |
 |
@StckPro $NBIX NEW ARTICLE : Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of… https://t.co/42E36rvbRh April 8th 2021, 8:04pm |
|
@otcdynamics $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology’s 73… https://t.co/3AmJYueo3m April 8th 2021, 8:04pm |
|
@stock_titan $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73… https://t.co/jmhW7odS7G April 8th 2021, 8:04pm |
 |
@sbwcws Neurocrine treatment of EECSWS granted FDA orphan designation $NBIX April 8th 2021, 7:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
